Clinical Trials Logo

Clinical Trial Details — Status: Unknown status

Administrative data

NCT number NCT02371343
Other study ID # SamiUlusCH
Secondary ID
Status Unknown status
Phase N/A
First received February 19, 2015
Last updated February 24, 2015
Start date March 2015
Est. completion date September 2016

Study information

Verified date February 2015
Source Dr. Sami Ulus Children's Hospital
Contact Dilek Dilli, Assoc Prof
Phone +905422368250
Email dilekdilli2@yahoo.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Gestational diabetes is the development of diabetes during pregnancy. Left untreated, gestational diabetes and preeclampsia can lead to serious -- or even fatal -- complications for both mother and child. Some evidence suggesting omega-3 fatty acids might help protect women from two serious pregnancy complications -- gestational diabetes and preeclampsia. Omega-3 fatty acids, in particular Docosahexaenoic acid (DHA), help a pregnant woman give her developing baby every advantage in life starting in-utero. Recent studies suggested that the biologic processes underlying the observed associations may involve epigenetic changes, specifically DNA methylation. In this study the investigators aimed to examine the effect of fish oil supplementation in women with gestational diabetes mellitus on newborn outcomes and insulin like growth factor 1 DNA methylation.


Description:

Gestational diabetes is the development of diabetes during pregnancy. According to the National Institutes of Health, gestational diabetes occurs in about 5 percent of all pregnancies in the United States, resulting in about 200,000 cases a year. Treatment involves dietary measures, exercise and, in some cases, insulin injections. All pregnant women should be taking a prescribed pre-natal vitamin, and should also supplement with fish oil or another source of omega-3 fatty acids to help support the nervous system of their developing child.

Left untreated, gestational diabetes and preeclampsia can lead to serious -- or even fatal -- complications for both mother and child. In diabetic pregnancies there is an increased risk of birth defects. Some evidence suggesting omega-3 fatty acids might help protect women from two serious pregnancy complications -- gestational diabetes and preeclampsia. Omega-3 fatty acids, in particular Docosahexaenoic acid (DHA), help a pregnant woman give her developing baby every advantage in life starting in-utero. In general the omega-3 fatty acids found in fish help the cardiovascular system, the brain (including moods), and even the brain and eyes of a developing baby. The risk of pre-term delivery and low birth weight is three and a half times higher when mothers are deficient in DHA. Recent studies suggested that the biologic processes underlying the observed associations may involve epigenetic changes, specifically DNA methylation. In this study the investigators aimed to examine the effect of fish oil supplementation in women with gestational diabetes mellitus on newborn outcomes and insulin like growth factor 1 DNA methylation.


Recruitment information / eligibility

Status Unknown status
Enrollment 100
Est. completion date September 2016
Est. primary completion date March 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria:

- Women who were diagnosed as gestational diabetes mellitus (GDM) between 24 and 28th week of pregnancy

- Women with GDM and accepted to be participate in the study

- Women younger that 40 years old

- The newborns of the women with GDM

Exclusion Criteria:

- The history of Type 1 diabetes melitus

- Abnormal glucose tolerance <20th gestational week

- The history of chronic illness in the mother

- Women who eat fish <2 times in a week

- Any history of sea-food allergy in the mother

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Fish oil, Ocean plus
Ocean Plus, 1200 mg, EPA 384 mg DHA 252 mg, total omega-3 782 mg, 50 soft gel, Ocean®, Germany
Sunflower Oil


Locations

Country Name City State
Turkey Sami Ulus CH Ankara

Sponsors (1)

Lead Sponsor Collaborator
Dr. Sami Ulus Children's Hospital

Country where clinical trial is conducted

Turkey, 

References & Publications (2)

Guermouche B, Soulimane-Mokhtari NA, Bouanane S, Merzouk H, Merzouk S, Narce M. Effect of dietary n - 3 polyunsaturated fatty acids on oxidant/antioxidant status in macrosomic offspring of diabetic rats. Biomed Res Int. 2014;2014:368107. doi: 10.1155/2014 — View Citation

Soulimane-Mokhtari NA, Guermouche B, Yessoufou A, Saker M, Moutairou K, Hichami A, Merzouk H, Khan NA. Modulation of lipid metabolism by n-3 polyunsaturated fatty acids in gestational diabetic rats and their macrosomic offspring. Clin Sci (Lond). 2005 Sep — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Birth size Birth size of the newborns 1 year
Secondary Insulin like growth factor DNA methylation Insulin like growth factor DNA methylation 1 year
See also
  Status Clinical Trial Phase
Completed NCT00826904 - Regulation Of Maternal Fuel Supply And Neonatal Adiposity
Recruiting NCT06157684 - Timing of Ambulation and Infant Birth Weight in Gestational Diabetes N/A
Completed NCT02713568 - Estimation of Fetal Weight by MR Imaging to PREdict Neonatal MACROsomia (PREMACRO Study) N/A
Recruiting NCT03451838 - Prediction of Fetal Macrosomia by US
Recruiting NCT02473991 - Correlation Between Placental Thickness in the Second and Third Trimester and Fetal Weight N/A
Completed NCT02523222 - Prophylactic Dextrose Gel for Newborns at High-risk for Hypoglycemia N/A
Completed NCT03002246 - Automated Fetal Weight Estimation: A Multicenter Validation Using Fractional Limb Volume
Recruiting NCT04399434 - Gut Microbiota, SCFAs and Glucolipid Metabolism in Pregnant Women With Abnormal Fetal Size and Their Newborns
Completed NCT00625781 - Treatment of Impaired Glucose Tolerance in Pregnancy N/A
Completed NCT00190320 - DAME: Induction of Labor or Waiting for Suspicion Fetal Macrosomia Phase 4
Not yet recruiting NCT06268392 - A Comparative Study of AI Methods for Fetal Diagnostic Accuracy in Ultrasound
Recruiting NCT06067685 - Investigating the Relationship Between Triglycerides and Fetal Overgrowth in Gestational Diabetes
Completed NCT03232294 - Fetal Front-abdominal Wall Thickness and Perinatal Outcome N/A